Vertex Pharmaceuticals Incorporated Stock
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
445.9 USD | +0.15% | +3.71% | +9.58% |
May. 15 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
May. 14 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
Financials (USD)
Sales 2024 * | 10.75B | Sales 2025 * | 11.67B | Capitalization | 115B |
---|---|---|---|---|---|
Net income 2024 * | 3.99B | Net income 2025 * | 4.46B | EV / Sales 2024 * | 9.4 x |
Net cash position 2024 * | 13.97B | Net cash position 2025 * | 19.01B | EV / Sales 2025 * | 8.23 x |
P/E ratio 2024 * |
29.3
x | P/E ratio 2025 * |
26.1
x | Employees | 5,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.88% |
Latest transcript on Vertex Pharmaceuticals Incorporated
1 day | +0.15% | ||
1 week | +3.71% | ||
Current month | +13.51% | ||
1 month | +13.08% | ||
3 months | +6.00% | ||
6 months | +24.95% | ||
Current year | +9.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 17-01-31 | |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Charles Wagner
DFI | Director of Finance/CFO | 55 | 19-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Garber
BRD | Director/Board Member | 68 | 17-06-07 |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Bruce Sachs
BRD | Director/Board Member | 64 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.67% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 445.9 | +0.15% | 742,237 |
24-05-17 | 445.2 | +1.04% | 1,382,490 |
24-05-16 | 440.6 | +0.72% | 1,215,998 |
24-05-15 | 437.5 | +2.08% | 1,059,443 |
24-05-14 | 428.6 | -0.31% | 935,891 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 107B | |
-2.59% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- VRTX Stock